Cooperation between HMGN1 and these specific fusion oncogenes is interesting given that AML-ETO promotes HSPC self-renewal and leukemia via CBP/p300 acetylation40 and MOZ is a HAT that depends on HAT activity to inhibit senescence41. The gene discussed is HMGN1; the disease is acute myeloid leukemia.